{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:18:06Z","timestamp":1790421486958,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"35","license":[{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25290048"],"award-info":[{"award-number":["25290048"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K16752"],"award-info":[{"award-number":["19K16752"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Grant of the Princess Takamatsu Cancer Research Fund"},{"name":"National Cancer Center Research and Development Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2020,8,27]]},"DOI":"10.1038\/s41388-020-01393-x","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T01:02:28Z","timestamp":1596502948000},"page":"5782-5794","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Autocrine HGF\/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell leukemia\/lymphoma"],"prefix":"10.1038","volume":"39","author":[{"given":"Haruhito","family":"Totani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Shinjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7770-432X","authenticated-orcid":false,"given":"Keisuke","family":"Katsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Mase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asahi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9617-486X","authenticated-orcid":false,"given":"Masaki","family":"Ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Kusumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3746-3191","authenticated-orcid":false,"given":"Yutaka","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,4]]},"reference":[{"key":"1393_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","volume":"50","author":"T Uchiyama","year":"1977","unstructured":"Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50:481\u201392.","journal-title":"Blood"},{"key":"1393_CR2","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 1980;77:7415\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1393_CR3","doi-asserted-by":"publisher","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","volume":"78","author":"Y Hinuma","year":"1981","unstructured":"Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA. 1981;78:6476\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1393_CR4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"M Shimoyama","year":"1991","unstructured":"Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984\u201387). Br J Haematol. 1991;79:428\u201337.","journal-title":"Br J Haematol"},{"key":"1393_CR5","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1182\/blood-2015-03-632489","volume":"126","author":"H Katsuya","year":"2015","unstructured":"Katsuya H, Ishitsuka K, Utsunomiya A, Hanada S, Eto T, Moriuchi Y, et al. Treatment and survival among 1594 patients with ATL. Blood. 2015;126:2570\u20137.","journal-title":"Blood"},{"key":"1393_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3109\/10428199709051782","volume":"26","author":"Y Yamada","year":"1997","unstructured":"Yamada Y, Kamihira S, Murata K, Yamamura M, Maeda T, Tsukasaki K, et al. Frequent hepatic involvement in adult T cell leukemia: comparison with non-Hodgkin\u2019s lymphoma. Leuk Lymphoma. 1997;26:327\u201335.","journal-title":"Leuk Lymphoma"},{"key":"1393_CR7","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1182\/blood.V99.5.1505","volume":"99","author":"O Yoshie","year":"2002","unstructured":"Yoshie O, Fujisawa R, Nakayama T, Harasawa H, Tago H, Izawa D, et al. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. Blood. 2002;99:1505\u201311.","journal-title":"Blood"},{"key":"1393_CR8","doi-asserted-by":"publisher","first-page":"931","DOI":"10.4049\/jimmunol.180.2.931","volume":"180","author":"K Hieshima","year":"2008","unstructured":"Hieshima K, Nagakubo D, Nakayama T, Shirakawa AK, Jin Z, Yoshie O. Tax-inducible production of CC chemokine ligand 22 by human T cell leukemia virus type 1 (HTLV-1)-infected T cells promotes preferential transmission of HTLV-1 to CCR4-expressing CD4+ T cells. J Immunol. 2008;180:931\u20139.","journal-title":"J Immunol"},{"key":"1393_CR9","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","volume":"30","author":"T Ishida","year":"2012","unstructured":"Ishida T, Joh T, Uike N, Yamamoto K, Utsunomiya A, Yoshida S, et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol. 2012;30:837\u201342.","journal-title":"J Clin Oncol"},{"key":"1393_CR10","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/bjh.13338","volume":"169","author":"T Ishida","year":"2015","unstructured":"Ishida T, Jo T, Takemoto S, Suzushima H, Uozumi K, Yamamoto K, et al. Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study. Br J Haematol. 2015;169:672\u201382.","journal-title":"Br J Haematol"},{"key":"1393_CR11","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1111\/cas.13343","volume":"108","author":"T Ishida","year":"2017","unstructured":"Ishida T, Utsunomiya A, Jo T, Yamamoto K, Kato K, Yoshida S, et al. Mogamulizumab for relapsed adult T-cell leukemia-lymphoma: updated follow-up analysis of phase I and II studies. Cancer Sci. 2017;108:2022\u20139.","journal-title":"Cancer Sci"},{"key":"1393_CR12","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1182\/blood-2010-12-327791","volume":"117","author":"A Umino","year":"2011","unstructured":"Umino A, Nakagawa M, Utsunomiya A, Tsukasaki K, Taira N, Katayama N, et al. Clonal evolution of adult T-cell leukemia\/lymphoma takes place in the lymph nodes. Blood. 2011;117:5473\u20138.","journal-title":"Blood"},{"key":"1393_CR13","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/ng.3415","volume":"47","author":"K Kataoka","year":"2015","unstructured":"Kataoka K, Nagata Y, Kitanaka A, Shiraishi Y, Shimamura T, Yasunaga J, et al. Integrated molecular analysis of adult T cell leukemia\/lymphoma. Nat Genet. 2015;47:1304\u201315.","journal-title":"Nat Genet"},{"key":"1393_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ccr.2011.12.015","volume":"21","author":"M Yamagishi","year":"2012","unstructured":"Yamagishi M, Nakano K, Miyake A, Yamochi T, Kagami Y, Tsutsumi A, et al. Polycomb-mediated loss of miR-31 activates NIK-dependent NF-kappaB pathway in adult T cell leukemia and other cancers. Cancer Cell. 2012;21:121\u201335.","journal-title":"Cancer Cell"},{"key":"1393_CR15","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1182\/blood-2015-08-662593","volume":"127","author":"D Fujikawa","year":"2016","unstructured":"Fujikawa D, Nakagawa S, Hori M, Kurokawa N, Soejima A, Nakano K, et al. Polycomb-dependent epigenetic landscape in adult T-cell leukemia. Blood. 2016;127:1790\u2013802.","journal-title":"Blood"},{"key":"1393_CR16","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1016\/j.celrep.2019.10.083","volume":"29","author":"M Yamagishi","year":"2019","unstructured":"Yamagishi M, Hori M, Fujikawa D, Ohsugi T, Honma D, Adachi N, et al. Targeting excessive EZH1 and EZH2 activities for abnormal histone methylation and transcription network in malignant lymphomas. Cell Rep. 2019;29:2321\u201337.e2327.","journal-title":"Cell Rep."},{"key":"1393_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0922-1","volume":"9","author":"X Ding","year":"2018","unstructured":"Ding X, Ji J, Jiang J, Cai Q, Wang C, Shi M, et al. HGF-mediated crosstalk between cancer-associated fibroblasts and MET-unamplified gastric cancer cells activates coordinated tumorigenesis and metastasis. Cell Death Dis. 2018;9:867.","journal-title":"Cell Death Dis"},{"key":"1393_CR18","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1158\/1078-0432.CCR-16-0951","volume":"22","author":"S Hartmann","year":"2016","unstructured":"Hartmann S, Bhola NE, Grandis JR. HGF\/Met signaling in head and neck cancer: impact on the tumor microenvironment. Clin Cancer Res. 2016;22:4005\u201313.","journal-title":"Clin Cancer Res"},{"key":"1393_CR19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/onc.2013.539","volume":"34","author":"Y Kwon","year":"2015","unstructured":"Kwon Y, Smith BD, Zhou Y, Kaufman MD, Godwin AK. Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment. Oncogene. 2015;34:144\u201353.","journal-title":"Oncogene"},{"key":"1393_CR20","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/sj.onc.1209898","volume":"26","author":"YL Choi","year":"2007","unstructured":"Choi YL, Tsukasaki K, O\u2019Neill MC, Yamada Y, Onimaru Y, Matsumoto K, et al. A genomic analysis of adult T-cell leukemia. Oncogene. 2007;26:1245\u201355.","journal-title":"Oncogene"},{"key":"1393_CR21","first-page":"181","volume":"9","author":"Y Imaizumi","year":"2003","unstructured":"Imaizumi Y, Murota H, Kanda S, Hishikawa Y, Koji T, Taguchi T, et al. Expression of the c-Met proto-oncogene and its possible involvement in liver invasion in adult T-cell leukemia. Clin Cancer Res. 2003;9:181\u20137.","journal-title":"Clin Cancer Res"},{"key":"1393_CR22","first-page":"697","volume":"33","author":"Y Onimaru","year":"2008","unstructured":"Onimaru Y, Tsukasaki K, Murata K, Imaizumi Y, Choi YL, Hasegawa H, et al. Autocrine and\/or paracrine growth of aggressive ATLL cells caused by HGF and c-Met. Int J Oncol. 2008;33:697\u2013703.","journal-title":"Int J Oncol"},{"key":"1393_CR23","doi-asserted-by":"publisher","first-page":"e46255.","DOI":"10.15252\/embr.201846255","volume":"19","author":"S Oki","year":"2018","unstructured":"Oki S, Ohta T, Shioi G, Hatanaka H, Ogasawara O, Okuda Y, et al. ChIP-Atlas: a data-mining suite powered by full integration of public ChIP-seq data. EMBO Rep. 2018;19:e46255.","journal-title":"EMBO Rep"},{"key":"1393_CR24","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1182\/blood-2005-09-3801","volume":"107","author":"A Oshiro","year":"2006","unstructured":"Oshiro A, Tagawa H, Ohshima K, Karube K, Uike N, Tashiro Y, et al. Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia\/lymphoma. Blood. 2006;107:4500\u20137.","journal-title":"Blood"},{"key":"1393_CR25","doi-asserted-by":"publisher","first-page":"5410","DOI":"10.1200\/JCO.2008.21.6150","volume":"27","author":"RL Piekarz","year":"2009","unstructured":"Piekarz RL, Frye R, Turner M, Wright JJ, Allen SL, Kirschbaum MH, et al. Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma. J Clin Oncol. 2009;27:5410\u20137.","journal-title":"J Clin Oncol"},{"key":"1393_CR26","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.1182\/blood-2010-10-312603","volume":"117","author":"RL Piekarz","year":"2011","unstructured":"Piekarz RL, Frye R, Prince HM, Kirschbaum MH, Zain J, Allen SL, et al. Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma. Blood. 2011;117:5827\u201334.","journal-title":"Blood"},{"key":"1393_CR27","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1200\/JCO.2006.10.2434","volume":"25","author":"EA Olsen","year":"2007","unstructured":"Olsen EA, Kim YH, Kuzel TM, Pacheco TR, Foss FM, Parker S, et al. Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma. J Clin Oncol. 2007;25:3109\u201315.","journal-title":"J Clin Oncol"},{"key":"1393_CR28","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ccell.2018.06.014","volume":"34","author":"M Nakagawa","year":"2018","unstructured":"Nakagawa M, Shaffer AL 3rd, Ceribelli M, Zhang M, Wright G, Huang DW, et al. Targeting the HTLV-I-regulated BATF3\/IRF4 transcriptional network in adult T Cell Leukemia\/Lymphoma. Cancer Cell. 2018;34:286\u2013297.e210.","journal-title":"Cancer Cell"},{"key":"1393_CR29","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1182\/blood-2005-08-3141","volume":"108","author":"S Rutella","year":"2006","unstructured":"Rutella S, Bonanno G, Procoli A, Mariotti A, de Ritis DG, Curti A, et al. Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low\/neg accessory cells with dendritic-cell features. Blood. 2006;108:218\u201327.","journal-title":"Blood"},{"key":"1393_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-247","volume":"10","author":"G Bonanno","year":"2012","unstructured":"Bonanno G, Mariotti A, Procoli A, Folgiero V, Natale D, De Rosa L, et al. Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma. J Transl Med. 2012;10:247.","journal-title":"J Transl Med"},{"key":"1393_CR31","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1158\/1078-0432.CCR-14-2275","volume":"21","author":"A Masaki","year":"2015","unstructured":"Masaki A, Ishida T, Maeda Y, Suzuki S, Ito A, Takino H, et al. Prognostic significance of tryptophan catabolism in adult T-cell Leukemia\/Lymphoma. Clin Cancer Res. 2015;21:2830\u20139.","journal-title":"Clin Cancer Res"},{"key":"1393_CR32","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/S0959-8049(01)00164-2","volume":"37","author":"G Skibinski","year":"2001","unstructured":"Skibinski G, Skibinska A, James K. Hepatocyte growth factor (HGF) protects c-met-expressing Burkitt\u2019s lymphoma cell lines from apoptotic death induced by DNA damaging agents. Eur J Cancer. 2001;37:1562\u20139.","journal-title":"Eur J Cancer"},{"key":"1393_CR33","first-page":"155","volume":"71","author":"I Miyoshi","year":"1980","unstructured":"Miyoshi I, Kubonishi I, Sumida M, Hiraki S, Tsubota T, Kimura I, et al. A novel T-cell line derived from adult T-cell leukemia. Gan. 1980;71:155\u20136.","journal-title":"Gan"},{"key":"1393_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/ijc.2910340213","volume":"34","author":"K Sugamura","year":"1984","unstructured":"Sugamura K, Fujii M, Kannagi M, Sakitani M, Takeuchi M, Hinuma Y. Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus. Int J Cancer. 1984;34:221\u20138.","journal-title":"Int J Cancer"},{"key":"1393_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0165-4608(88)90171-9","volume":"34","author":"T Naoe","year":"1988","unstructured":"Naoe T, Akao Y, Yamada K, Utsumi KR, Koike K, Shamoto M, et al. Cytogenetic characterization of a T-cell line, ATN-1, derived from adult T-cell leukemia cells. Cancer Genet Cytogenet. 1988;34:77\u201388.","journal-title":"Cancer Genet Cytogenet"},{"key":"1393_CR36","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1111\/j.1349-7006.2012.02371.x","volume":"103","author":"S Suzuki","year":"2012","unstructured":"Suzuki S, Masaki A, Ishida T, Ito A, Mori F, Sato F, et al. Tax is a potential molecular target for immunotherapy of adult T-cell leukemia\/lymphoma. Cancer Sci. 2012;103:1764\u201373.","journal-title":"Cancer Sci"},{"key":"1393_CR37","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3324\/haematol.2011.056101","volume":"97","author":"C Xu","year":"2012","unstructured":"Xu C, Plattel W, van den Berg A, Ruther N, Huang X, Wang M, et al. Expression of the c-Met oncogene by tumor cells predicts a favorable outcome in classical Hodgkin\u2019s lymphoma. Haematologica. 2012;97:572\u20138.","journal-title":"Haematologica"},{"key":"1393_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/jb\/mvz007","volume":"166","author":"A Murashima","year":"2019","unstructured":"Murashima A, Shinjo K, Katsushima K, Onuki T, Kondoh Y, Osada H, et al. Identification of a chemical modulator of EZH2-mediated silencing by cell-based high-throughput screening assay. J Biochem. 2019;166:41\u201350.","journal-title":"J Biochem"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01393-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01393-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01393-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T23:10:08Z","timestamp":1628032208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01393-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,4]]},"references-count":38,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2020,8,27]]}},"alternative-id":["1393"],"URL":"https:\/\/doi.org\/10.1038\/s41388-020-01393-x","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,4]]},"assertion":[{"value":"23 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}